Nomura Micro Science Balance Sheet Health
Financial Health criteria checks 4/6
Nomura Micro Science has a total shareholder equity of ¥28.9B and total debt of ¥22.4B, which brings its debt-to-equity ratio to 77.4%. Its total assets and total liabilities are ¥70.6B and ¥41.7B respectively. Nomura Micro Science's EBIT is ¥10.6B making its interest coverage ratio 21.8. It has cash and short-term investments of ¥12.1B.
Key information
77.4%
Debt to equity ratio
JP¥22.38b
Debt
| Interest coverage ratio | 21.8x |
| Cash | JP¥12.14b |
| Equity | JP¥28.92b |
| Total liabilities | JP¥41.68b |
| Total assets | JP¥70.60b |
Recent financial health updates
Recent updates
Nomura Micro Science's (TSE:6254) Solid Earnings May Rest On Weak Foundations
May 22
Is Nomura Micro Science (TSE:6254) Using Too Much Debt?
Apr 30Here's Why We Think Nomura Micro Science (TSE:6254) Is Well Worth Watching
Apr 14Should You Investigate Nomura Micro Science Co., Ltd. (TSE:6254) At JP¥5,940?
Mar 30Nomura Micro Science (TSE:6254) Is Due To Pay A Dividend Of ¥100.00
Mar 15Shareholders Would Enjoy A Repeat Of Nomura Micro Science's (TSE:6254) Recent Growth In Returns
Mar 13Nomura Micro Science Co., Ltd.'s (TSE:6254) 34% Share Price Surge Not Quite Adding Up
Feb 28Nomura Micro Science's (TSE:6254) Dividend Will Be ¥100.00
Feb 27Financial Position Analysis
Short Term Liabilities: 6254's short term assets (¥65.5B) exceed its short term liabilities (¥41.3B).
Long Term Liabilities: 6254's short term assets (¥65.5B) exceed its long term liabilities (¥400.0M).
Debt to Equity History and Analysis
Debt Level: 6254's net debt to equity ratio (35.4%) is considered satisfactory.
Reducing Debt: 6254's debt to equity ratio has increased from 41.8% to 77.4% over the past 5 years.
Debt Coverage: 6254's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 6254's interest payments on its debt are well covered by EBIT (21.8x coverage).